{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T10:18:00Z","timestamp":1783160280436,"version":"3.54.6"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010618","name":"Guangzhou University of Chinese Medicine","doi-asserted-by":"publisher","award":["GZYZS2024D02"],"award-info":[{"award-number":["GZYZS2024D02"]}],"id":[{"id":"10.13039\/501100010618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474379"],"award-info":[{"award-number":["82474379"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104504"],"award-info":[{"award-number":["82104504"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82574907"],"award-info":[{"award-number":["82574907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82174266"],"award-info":[{"award-number":["82174266"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81974520"],"award-info":[{"award-number":["81974520"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","award":["2025A04J3785"],"award-info":[{"award-number":["2025A04J3785"]}],"id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpba.2026.117548","type":"journal-article","created":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T22:01:14Z","timestamp":1777932074000},"page":"117548","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Differences in hepatic metabolism of Liandan Xiaoyan Formula between control and ulcerative colitis mice associated with FXR\/PXR-CYP450 changes"],"prefix":"10.1016","volume":"278","author":[{"given":"Baojun","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingshuang","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengyu","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyao","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozhan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangle","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenchen","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2026.117548_bib1","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/S0140-6736(16)32126-2","article-title":"Ulcerative colitis","volume":"389","author":"Ungaro","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.jpba.2026.117548_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1124\/dmd.114.061093","article-title":"Inflammation-induced phenoconversion of polymorphic drug metabolizing enzymes: hypothesis with implications for personalized medicine","volume":"43","author":"Shah","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2026.117548_bib3","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tips.2016.05.006","article-title":"Recent structural insights into cytochrome P450 function","volume":"37","author":"Guengerich","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2026.117548_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00008571-200401000-00001","article-title":"Comparison of cytochrome P450 (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants","volume":"14","author":"Nelson","year":"2004","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.jpba.2026.117548_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0090-9556(24)15284-1","article-title":"Effect of methanol, ethanol, dimethyl sulfoxide, and acetonitrile on in vitro activities of cDNA-expressed human cytochromes P-450","volume":"27","author":"Busby","year":"1999","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2026.117548_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.cgh.2023.05.023","article-title":"Curcumin-QingDai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial","volume":"22","author":"Ben-Horin","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2026.117548_bib7","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jgh.12966","article-title":"Expression of hepatic cytochrome P450 in a mouse model of ulcerative colitis changes with pathological conditions","volume":"30","author":"Kusunoki","year":"2015","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jpba.2026.117548_bib8","first-page":"863","article-title":"Mechanism study of Liandan Xiaoyan Formula on attenuating ulcerative colitis based on analysis of absorbed constituents in blood","volume":"44","author":"Lu","year":"2021","journal-title":"J. Chin. Med. Mater."},{"key":"10.1016\/j.jpba.2026.117548_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.115115","article-title":"A comparative study of Liandan Xiaoyan Formula metabolic profiles in control and colitis rats by UPLC-Q-TOF-MS combined with chemometrics","volume":"223","author":"Wang","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117548_bib10","article-title":"Pharmacokinetic study of four major bioactive components of Liandan Xiaoyan Formula in ulcerative colitis and control rats using UPLC-MS\/MS","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.apsb.2019.12.002","article-title":"Hepatic and intestinal biotransformation gene expression and drug disposition in a dextran sulfate sodium-induced colitis mouse model","volume":"10","author":"Fan","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jpba.2026.117548_bib12","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/ptr.7324","article-title":"Andrographolide: a review of its pharmacology, pharmacokinetics, toxicity and clinical trials and pharmaceutical researches","volume":"36","author":"Zeng","year":"2022","journal-title":"Phytother. Res."},{"key":"10.1016\/j.jpba.2026.117548_bib13","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jchromb.2015.03.014","article-title":"Simultaneous determination of andrographolide, dehydroandrographolide and neoandrographolide in dog plasma by LC-MS\/MS and its application to a dog pharmacokinetic study of Andrographis paniculata tablet","volume":"990","author":"Xu","year":"2015","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2026.117548_bib14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/j.1476-5381.2010.00836.x","article-title":"14-Deoxyandrographolide desensitizes hepatocytes to tumour necrosis factor-alpha-induced apoptosis through calcium-dependent tumour necrosis factor receptor superfamily member 1A release via the NO\/cGMP pathway","volume":"160","author":"Roy","year":"2010","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib15","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/mrc.2602","article-title":"\u03b2-Carboline alkaloids from the stems of Picrasma quassioides","volume":"48","author":"Jiao","year":"2010","journal-title":"Magn. Reson. Chem."},{"key":"10.1016\/j.jpba.2026.117548_bib16","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jchromb.2015.02.008","article-title":"Simultaneous quantification of two canthinone alkaloids of Picrasma quassioides in rat plasma by liquid chromatography-tandem mass spectrometry and its application to a rat pharmacokinetic study","author":"Shi","year":"2015","journal-title":"J. Chromatogr. B 986987"},{"key":"10.1016\/j.jpba.2026.117548_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/bmc.4830","article-title":"Pharmacokinetic and bioavailability study of 5-hydroxy-4-methoxycanthin-6-one, a typical canthinone alkaloid, in rats using ultra-high performance liquid chromatography\/electrospray ionization tandem mass spectrometry","volume":"34","author":"Zhao","year":"2020","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2026.117548_bib18","doi-asserted-by":"crossref","first-page":"S427","DOI":"10.33549\/physiolres.933512","article-title":"Bile acids, nuclear receptors and cytochrome P450","volume":"65","author":"Ju\u0159ica","year":"2016","journal-title":"Physiol. Res."},{"key":"10.1016\/j.jpba.2026.117548_bib19","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.cmet.2024.06.008","article-title":"TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response","volume":"36","author":"Zheng","year":"2024","journal-title":"Cell Metab."},{"key":"10.1016\/j.jpba.2026.117548_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120867","article-title":"Expression of CYP450 enzymes in human fetal membranes and its implications in xenobiotic metabolism during pregnancy","volume":"307","author":"Kammala","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.jpba.2026.117548_bib21","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2174\/138920009790820138","article-title":"Expression, function and regulation of mouse cytochrome P450 enzymes: comparison with human P450 enzymes","volume":"10","author":"Hrycay","year":"2009","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.jpba.2026.117548_bib22","article-title":"Study on the liver drug's dominant metabolic enzymes for six effective components of the Huang qi Liuyi decoction","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/labinvest.2011.193","article-title":"Carbon tetrachloride-mediated lipid peroxidation induces early mitochondrial alterations in mouse liver","volume":"92","author":"Knockaert","year":"2012","journal-title":"Lab. Invest"},{"key":"10.1016\/j.jpba.2026.117548_bib24","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1111\/j.1476-5381.1995.tb17217.x","article-title":"Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6","volume":"116","author":"Kinonen","year":"1995","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib25","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1161\/01.HYP.0000208299.62535.58","article-title":"Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling","volume":"47","author":"Pokreisz","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/j.jpba.2026.117548_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123162","article-title":"3F-\u03b1-pyrrolydinovalerophenone (3F-\u03b1-PVP) in vitro human metabolism: multiple in silico predictions to assist in LC-HRMS\/MS analysis and targeted\/untargeted data mining","volume":"1193","author":"Carlier","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2026.117548_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116696","article-title":"Rapid and accurate metabolite identification of traditional Chinese medicine based on UPLC-Q-TOF-MS coupled with UNIFI analysis platform and quantitative structure-retention relationship: Danshen-Honghua herbal pair as an example","volume":"257","author":"Chen","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117548_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.jpba.2012.06.007","article-title":"Approach to develop a standardized TLC-DPPH\u2219 test for assessing free radical scavenging properties of selected phenolic compounds","volume":"70","author":"Cie\u015bla","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117548_bib29","doi-asserted-by":"crossref","DOI":"10.1002\/cpph.9","article-title":"In Vitro drug metabolism using liver microsomes","volume":"74","author":"Knights","year":"2016","journal-title":"Curr. Protoc. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116886","article-title":"UPLC-Q-TOF\/MS-based study on chemical composition, in vivo metabolites, and tissue distribution of ethanol extract of Ganoderma lucidum","volume":"263","author":"Lin","year":"2025","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117548_bib31","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.3390\/genes11121509","article-title":"Distinct effects of inflammation on cytochrome P450 regulation and drug metabolism: lessons from experimental models and a potential role for pharmacogenetics","volume":"11","author":"de Jong","year":"2020","journal-title":"Genes"},{"key":"10.1016\/j.jpba.2026.117548_bib32","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1021\/acs.molpharmaceut.2c00890","article-title":"Activated hepatic nuclear factor-\u03baB in experimental colitis regulates CYP2A5 and metronidazole disposition","volume":"20","author":"Ma","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115763","article-title":"The chemical constituents and metabolite profiles of Huangqin decoction in normal and ulcerative colitis rats by UHPLC-Q-TOF\/MS analysis","volume":"237","author":"Tang","year":"2024","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2026.117548_bib34","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.55730\/1300-0144.5482","article-title":"Complementary medicines used in ulcerative colitis and unintended interactions with cytochrome P450-dependent drug-metabolizing enzymes","volume":"52","author":"Sen","year":"2022","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.jpba.2026.117548_bib35","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1124\/dmd.105.008870","article-title":"Expression, purification, and characterization of mouse CYP2D22","volume":"34","author":"Yu","year":"2006","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2026.117548_bib36","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1124\/mol.112.080036","article-title":"Generation and characterization of novel cytochrome P450 Cyp2c gene cluster knockout and CYP2C9 humanized mouse lines","volume":"82","author":"Scheer","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3109\/00498254.2014.945196","article-title":"Chemical inhibitors of CYP450 enzymes in liver microsomes: combining selectivity and unbound fractions to guide selection of appropriate concentration in phenotyping assays","volume":"45","author":"Nirogi","year":"2015","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2026.117548_bib38","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1007\/s11095-013-1006-7","article-title":"Hepatocyte nuclear factor 4 alpha and farnesoid X receptor co-regulates gene transcription in mouse livers on a genome-wide scale","volume":"30","author":"Thomas","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jpba.2026.117548_bib39","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.bcp.2015.01.001","article-title":"Hepatocyte nuclear factor (HNF) 4\u03b1 transactivation of cytochrome P450 (Cyp) 2d40 promoter is enhanced during pregnancy in mice","volume":"94","author":"Ning","year":"2015","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/MPG.0000000000002759","article-title":"Intestinal inflammation alters the expression of hepatic bile acid receptors causing liver impairment","volume":"71","author":"Negroni","year":"2020","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.jpba.2026.117548_bib41","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s41598-020-58644-w","article-title":"Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn\u2019s disease","volume":"10","author":"Wilson","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jpba.2026.117548_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/dmd.111.042754","article-title":"Investigation of drug-drug interactions caused by human pregnane X receptor-mediated induction of CYP3A4 and CYP2C subfamilies in chimeric mice with a humanized liver","volume":"40","author":"Hasegawa","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2026.117548_bib43","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s40262-022-01169-4","article-title":"Altered bioavailability and pharmacokinetics in Crohn\u2019s disease: capturing systems parameters for PBPK to assist with predicting the fate of orally administered drugs","volume":"61","author":"Alrubia","year":"2022","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jpba.2026.117548_bib44","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/ueg2.12559","article-title":"A gastroenterologist\u2019s guide to drug interactions of small molecules for inflammatory bowel disease","volume":"12","author":"Harnik","year":"2024","journal-title":"U. Eur. Gastroenterol. J."},{"key":"10.1016\/j.jpba.2026.117548_bib45","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.3390\/jcm11061567","article-title":"Herb\u2013drug interaction in inflammatory diseases: review of phytomedicine and herbal supplements","volume":"11","author":"Lippert","year":"2022","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jpba.2026.117548_bib46","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/736431","article-title":"Pharmacokinetic interactions of herbs with cytochrome P450 and P-glycoprotein","volume":"2015","author":"Cho","year":"2015","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"10.1016\/j.jpba.2026.117548_bib47","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.3390\/ijms18112353","article-title":"Hepatotoxicity of herbal supplements mediated by modulation of cytochrome P450","volume":"18","author":"Brewer","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jpba.2026.117548_bib48","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2174\/1573408019666230601121657","article-title":"Updates on the interactions of herbs constituents with cytochrome P450 drug metabolizing enzymes","volume":"19","author":"Zaroug","year":"2023","journal-title":"Curr. Enzym. Inhib."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708526002165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T09:52:07Z","timestamp":1783158727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708526002165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"alternative-id":["S0731708526002165"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117548","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Differences in hepatic metabolism of Liandan Xiaoyan Formula between control and ulcerative colitis mice associated with FXR\/PXR-CYP450 changes","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2026.117548","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117548"}}